文献速递关节外科

无菌性翻修全髋关节置换术后再入院费用趋势的特征分析

Characterizing the Cost Trends of Readmissions After Aseptic Revision Total Hip Arthroplasty.
PubMed 文献 · J Arthroplasty · 2025-10-31

该回顾性分析利用2009年1月1日至2022年6月30日大型全国数据库,识别36,212例无菌性翻修全髋关节置换术患者,其中3,822例(10.6%)在术后90天内至少再入院一次。再入院中位费用为41,148美元,需再次手术者费用显著更高;导致再入院的主要手术并发症为假体周围关节感染、其他机械性并发症和脱位。再入院的显著危险因素包括初次翻修全髋关节置换术的不同指征以及病态肥胖、主动吸烟和风湿性疾病等合并症。

要点

  • 36,212例无菌性翻修全髋关节置换术中,3,822例(10.6%)在术后90天内至少再入院一次。
  • 再入院中位费用为41,148美元,需再次手术者费用显著更高。
  • 再入院主要手术并发症为假体周围关节感染、其他机械性并发症和脱位;危险因素包括不同翻修指征及病态肥胖、主动吸烟、风湿性疾病。

核心结论

  • 无菌性翻修全髋关节置换术后再入院对医疗系统造成显著经济负担,特定患者合并症和手术并发症影响术后再入院及额外费用。
  • 识别这些危险因素凸显了针对性的干预需求,以减少再入院频率和严重程度,从而改善患者结局并降低医疗支出。

研究设计与样本

  • 回顾性分析,使用2009年1月1日至2022年6月30日大型全国数据库数据。
  • 通过现行操作术语代码识别接受无菌性翻修全髋关节置换术的患者,分析术后90天内再入院。
  • 共纳入36,212例接受无菌性翻修全髋关节置换术的患者,其中3,822例(10.6%)在术后90天内至少再入院一次。

主要发现

  • 再入院中位费用为41,148美元,需再次手术者费用显著更高。
  • 导致再入院的主要手术并发症为假体周围关节感染、其他机械性并发症和脱位。
  • 再入院的显著危险因素包括初次翻修全髋关节置换术的不同指征,以及病态肥胖、主动吸烟和风湿性疾病等合并症。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: As the prevalence of primary total hip arthroplasty rises in the United States, there is a corresponding increase in revision total hip arthroplasty (rTHA), particularly among younger patients. This study explored the etiologies, financial burdens, and risk factors for 90-day readmission following aseptic rTHA, with an emphasis on distinguishing these factors from septic revision cases. METHODS: This retrospective analysis used data from a large national database from January 1, 2009, to June 30, 2022. Patients undergoing aseptic rTHA were identified via Current Procedural Terminology codes. Readmissions within 90 days postoperatively were analyzed. Baseline characteristics, comorbidities, and readmission costs were compared, and significant risk factors for readmission were identified. Of the 36,212 patients who underwent aseptic rTHA, 3,822 (10.6%) experienced at least one readmission within 90 days. RESULTS: The median cost of readmission was $41,148, with costs significantly higher in cases requiring reoperation. The primary surgical complications leading to readmission were periprosthetic joint infection, "other mechanical complications," and dislocation. Notable risk factors for readmission included different indications for index rTHA and comorbidities of morbid obesity, active smoking, and rheumatic disease. CONCLUSIONS: Readmission following aseptic rTHA places a significant economic burden on the health care system, with certain patient comorbidities and surgical complications influencing postoperative readmissions and additional costs. Identifying these risk factors underscores the need for targeted interventions aimed at minimizing the frequency and severity of readmissions, thereby enhancing patient outcomes and reducing healthcare expenditures.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Hrudka BT, Gordon S, Rodoni B, et al. Characterizing the Cost Trends of Readmissions After Aseptic Revision Total Hip Arthroplasty. J Arthroplasty. 2025. PMID: 41177189. doi:10.1016/j.arth.2025.10.064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。